Correction to: Oncogene
The original version of this article contained an error in the spelling of the author David Solow-Cordero, which was incorrectly given as David Solow-Codero.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nitta, R.T., Bolin, S., Luo, E. et al. Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene 39, 2029 (2020). https://doi.org/10.1038/s41388-019-1077-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-019-1077-y
This article is cited by
-
SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways
Experimental & Molecular Medicine (2023)
